期刊
CELL CALCIUM
卷 108, 期 -, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ceca.2022.102673
关键词
Calcium signaling; Chemoresistance; Calcium channels; Cancer; Potassium channels
类别
资金
- INSERM
- University of Tours
- Region center-Val de Loire
- Canceropole Grand Ouest
- Association CANCEN
- Tours' Hospital oncology association ACORT
- Ligue Contre le Cancer Grand-Ouest
Innate and acquired resistance play a significant role in the failure of cancer treatments. Calcium signaling, which regulates various cellular functions, has been implicated in cancer development. However, there is limited information on the role of calcium signaling in cancer drug resistance. This review discusses the potential value of targeting calcium signaling to overcome cancer resistance to therapeutic drugs.
Innate and acquired resistances to therapeutic agents are responsible for the failure of cancer treatments. Due to the multifactorial nature of resistance, the identification of new therapeutic targets is required to improve cancer treatment.Calcium is a universal second messenger that regulates many cellular functions such as proliferation, migra-tion, and survival. Calcium channels, pumps and exchangers tightly regulate the duration, location and magnitude of calcium signals. Many studies have implicated dysregulation of calcium signaling in several pa-thologies, including cancer. Abnormal calcium fluxes due to altered channel expression or activation contribute to carcinogenesis and promote tumor development. However, there is limited information on the role of calcium signaling in cancer resistance to therapeutic drugs. This review discusses the role of calcium signaling as a mediator of cancer resistance, and assesses the potential value of combining anticancer therapy with calcium signaling modulators to improve the effectiveness of current treatments.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据